Skip to main content
. 2020 Sep 2;110(2):220–227. doi: 10.1007/s00392-020-01734-6

Table 2.

Target vessels of study groups

Paclitaxel DCB (n = 429) Non-paclitaxel 2nd-generation DES (n = 1088) p value
LMS 10 (2.3) 34 (3.1) 0.41
LAD 229 (53.4) 545 (50.1) 0.25
Cx 76 (17.7) 135 (12.4) < 0.01*
RCA 77 (17.9) 250 (22.9) 0.03*
Graft 4 (0.9) 27 (2.4) 0.06
Multi-vessel PCI 33 (7.7) 97 (8.9) 0.44
Mean vessel diameter, mm 3.06 ± 0.56 3.39 ± 0.59 < 0.01*
Mean lesion length, mm 26.05 ± 11.95 30.03 ± 16.52 < 0.01*
Large vessels (diameter ≥ 3 mm) 320 (74.6) 925 (85) < 0.01*

Target vessels treated with DCB or DES

LMS left main stem, LAD left anterior descending artery, Cx circumflex, RCA right coronary artery, PCI percutaneous coronary intervention. Data are n (%) and *denotes significant result